BAYER HEALTHCARE Company Profile

✉ Email this page to a colleague

BAYER HEALTHCARE has twenty-nine approved drugs.

There are twenty-eight US patents protecting BAYER HEALTHCARE drugs. There is one tentative approval on BAYER HEALTHCARE drugs.

There are four hundred and thirty-three patent family members on BAYER HEALTHCARE drugs in fifty-nine countries and fifty supplementary protection certificates in seventeen countries.

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bayer Healthcare Llc	CHLOR-TRIMETON	chlorpheniramine maleate	TABLET, EXTENDED RELEASE;ORAL	007638-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Bayer Healthcare Llc	GYNE-LOTRIMIN 3	clotrimazole	CREAM;VAGINAL	020574-001	Nov 24, 1998		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Bayer Healthcare Llc	OCUCLEAR	oxymetazoline hydrochloride	SOLUTION/DROPS;OPHTHALMIC	018471-001	May 30, 1986		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Bayer Healthcare Llc	CLARITIN	loratadine	TABLET;ORAL	019658-002	Nov 27, 2002		OTC	Yes	Yes		⤷ Subscribe				⤷ Subscribe
Bayer Healthcare	NUBEQA	darolutamide	TABLET;ORAL	212099-001	Jul 30, 2019		RX	Yes	Yes	11,168,058	⤷ Subscribe	Y	Y		⤷ Subscribe
Bayer Healthcare Llc	GYNE-LOTRIMIN	clotrimazole	CREAM;VAGINAL	018052-002	Nov 30, 1990		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Bayer Healthcare	VITRAKVI	larotrectinib sulfate	SOLUTION;ORAL	211710-001	Nov 26, 2018		RX	Yes	Yes	9,676,783	⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bayer Healthcare Llc	MYCELEX	clotrimazole	CREAM;TOPICAL	018183-001	Approved Prior to Jan 1, 1982	3,705,172	⤷ Subscribe
Bayer Healthcare Llc	CLARITIN-D 24 HOUR	loratadine; pseudoephedrine sulfate	TABLET, EXTENDED RELEASE;ORAL	020470-002	Nov 27, 2002	5,314,697*PED	⤷ Subscribe
Bayer Healthcare Llc	CLARITIN-D 24 HOUR	loratadine; pseudoephedrine sulfate	TABLET, EXTENDED RELEASE;ORAL	020470-002	Nov 27, 2002	4,659,716*PED	⤷ Subscribe
Bayer Healthcare	ALIQOPA	copanlisib dihydrochloride	POWDER;INTRAVENOUS	209936-001	Sep 14, 2017	7,511,041	⤷ Subscribe
Bayer Healthcare Llc	CLARITIN	loratadine	SYRUP;ORAL	020641-002	Nov 27, 2002	4,659,716*PED	⤷ Subscribe
Bayer Healthcare Llc	CLARITIN	loratadine	TABLET;ORAL	019658-002	Nov 27, 2002	4,659,716*PED	⤷ Subscribe
Bayer Healthcare Llc	SHADE UVAGUARD	avobenzone; octinoxate; oxybenzone	LOTION;TOPICAL	020045-001	Dec 7, 1992	4,522,807	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration
Eurasian Patent Organization	201391470	⤷ Subscribe
World Intellectual Property Organization (WIPO)	2007090624	⤷ Subscribe
Poland	3372605	⤷ Subscribe
South Korea	101853026	⤷ Subscribe
Poland	2350071	⤷ Subscribe
Hungary	S2000006	⤷ Subscribe
Japan	6105008	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1986495	SPC/GB18/044	United Kingdom	⤷ Subscribe	PRODUCT NAME: SEDAXANE OR A TAUTOMER THEREOF, FLUDIOXONIL AND METALAXYL M; REGISTERED: NL NL 15544 N 20171229; UK MAPP NO. 18588 20180619
2493858	122020000030	Germany	⤷ Subscribe	PRODUCT NAME: DAROLUTAMID; NAT. REGISTRATION NO/DATE: EU/1/20/1432 20200327; FIRST REGISTRATION: EU EU/ 1/2011432 20200327
2493858	C02493858/01	Switzerland	⤷ Subscribe	PRODUCT NAME: DAROLUTAMIDUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67521 19.06.2020
3106463	722	Finland	⤷ Subscribe
2493858	LUC00154	Luxembourg	⤷ Subscribe	PRODUCT NAME: DAROLUTAMIDE EVENTUELLEMENT SOUS LA FORME D'UN SEL OU D'UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/20/1432/001 20200330
2493858	301041	Netherlands	⤷ Subscribe	PRODUCT NAME: DAROLUTAMIDE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN OF IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBARE ESTER DAARVAN; REGISTRATION NO/DATE: EU/1/20/1432 20200330
2493858	CR 2020 00020	Denmark	⤷ Subscribe	PRODUCT NAME: DAROLUTAMID EVENTUELT I FORM AF ET FARMACEUTISK ACCEPTABELT SALT ELLER EN FARMACEUTISK ACCEPTABELT ESTER DERAF; REG. NO/DATE: EU/1/20/1432/001 20200330
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.